Document:

Exhibit 4(b)(xii)

 

31 March 2014

 

Private & Confidential

 

Lord Norman Blackwell

 

Dear Norman

 

Chairman Appointment - Lloyds Banking Group plc

 

Following our recent discussions, I am pleased
to confirm that the Board has approved your appointment as Chairman of Lloyds Banking Group plc (“the company”) with
effect from 3 April 2014 at the conclusion of the Board meeting scheduled for that day. This follows confirmation from both the
Prudential Regulation Authority (PRA) and the Financial Conduct Authority (FCA) that they have no objection to your appointment
as Chairman.

 

The terms set out in this letter will apply
from the date of your appointment as Chairman. Prior to you being appointed to that role, the terms set out in your letter of 25
May 2012 remain in full force and effect.

 

		1	Appointment

 

		1.1	This letter covers your appointment as:

 

		(i)	Chairman of Lloyds Banking Group plc with effect from 3 April 2014 (or such other date as the Board
may determine)

 

		(ii)	A non executive director of Lloyds Banking Group plc and each of its principal subsidiaries (namely
Lloyds Bank plc, Bank of Scotland plc and HBOS plc) which commenced on 1 June 2012

 

		(iii)	Chairman and non executive director of Scottish Widows Group Ltd and its principal subsidiaries
(collectively referred to as the ‘Insurance Boards’) which you will continue to hold until a successor has been appointed.

 

Subject to satisfactory performance and
Board approval, you will be invited to stand for annual re-election by shareholders at the AGM in each year of your appointment.

 

		1.2	Your appointment is subject to the articles of association of the company from time to time in
force and the provisions of the Companies Act 2006. Continuation of each of your appointments mentioned in 1.1 above is subject
to:

 

		·	You meeting and maintaining, as applicable and throughout your period of office, the status and
standards laid down by the Prudential Regulatory Authority (PRA) and Financial Conduct Authority (FCA) (collectively referred to
as the Regulators) in relation to approved persons (or such other regime as may be in force from time to time). All directors are
required to adhere, on an ongoing basis, to the standards laid down by the Regulators in the Statements of Principle and Code of
Practice for Approved Persons (APER), a copy of which is available via the PRA website at http://fshandbook.info/FS/html/PRA/APER
or on request from the Company Secretary.

    	 

    	

    

		·	All directors are required to inform the Regulator and the Board promptly of any change in their
personal circumstances including but not limited to any matters relating to fitness and propriety which may have an impact on their
status as an approved person or their ability to remain as a director;

 

		·	satisfactory performance and contribution to the Board and any Board committees on which you serve;

 

		·	re-election as a director by the company’s shareholders in general meeting (including the
2014 Annual General Meeting) as required by the company’s articles of association and codes to which the company subscribes,
in particular, the Financial Reporting Council’s UK Corporate Governance Code.

 

		1.3	If (i) you are not re-elected by the shareholders at the company’s Annual General Meeting
from time to time, (ii) you fail to meet the standards required of approved persons (as outlined in 1.2 above), or (iii) the articles
of association of any company to which you are appointed pursuant to this letter or any law or regulation prevents you from continuing
in office, your appointment shall terminate automatically with immediate effect and without compensation. Otherwise, the company
may terminate your appointment and this agreement at any time, subject to six month’s written notice. If you wish to terminate
your appointment and this agreement, you must give the company six months’ written notice. If, following termination of your
appointment, you do not resign from the Board of the company, and the boards of the principal subsidiaries, having been requested
to do so, the company will be appointed as your attorney to effect your resignation. By countersigning this letter, you irrevocably
appoint the company as your attorney to act on your behalf to execute any document or to do anything in your name necessary to
effect your resignation in accordance with this letter. If there is any doubt as to whether such a document (or other thing) has
been carried out within the authority conferred by this paragraph, a certificate in writing (signed by any director or the Company
Secretary) will be sufficient to prove that the act (or thing) falls within that authority.

 

		2	Status of Appointment

 

Upon appointment as Chairman you
will become an employee of the company. This letter sets out the only consideration you will receive for performing your duties.
Accordingly, no other remuneration or benefits will be provided and, in particular, you will not participate in any of the company’s
senior executive incentive plans or pension schemes. For the avoidance of doubt if there is any conflict between this letter and
the terms of any staff handbook or staff manual issued to you, the terms of this letter will prevail.

 

		3	Board Committees

 

As Chairman of Lloyds Banking Group
plc, you will be required to chair the Nomination and Governance Committee. You will also serve as a member (but will not either
formally or informally, assume the Chair) of the Remuneration Committee. It is also envisaged that you will continue as a member
of the Risk Committee and an attendee of the Audit Committee.

 

		4	Role

 

The required responsibilities of
the Chairman are:

 

		·	leadership of the Board;

 

Page 2 of 7

    	 

    	

    

		·	promotion of the highest standards of corporate governance;

 

		·	oversight
                                                                                                              of the content of
                                                                                                              the Board meeting
                                                                                                              agendas1
                                                                                                              to ensure that the
                                                                                                              Board devotes its
                                                                                                              time and attention
                                                                                                              to the right matters.
                                                                                                              Agendas are finalised
                                                                                                              at Board Agenda
                                                                                                              Review meetings
                                                                                                              involving the Chairman,
                                                                                                              Group Chief Executive
                                                                                                              (GCE) and Company
                                                                                                              Secretary. The Deputy
                                                                                                              Chairman and Senior
                                                                                                              Independent Director
                                                                                                              also attend;

 

		·	effective communication with shareholders and development of understanding of the views of shareholders;

 

		·	leadership of and, with the assistance of the Company Secretary, attendance to the identification
and provision of induction, training and development needs for Directors and the Board generally;

 

		·	ensuring, with the support of the Company Secretary, that Directors receive timely and relevant
information, including all material risks, and are kept advised of key developments, both during and between formal meetings;

 

		·	encourage open dialogue between directors and to this end, meeting regularly with the Non-Executive
Directors in the absence of Executive Directors in private sessions;

 

		·	support and championing of the building and maintenance of a customer-focussed, open and transparent
culture;

 

		·	building an effective and complementary Board and, in conjunction with the Nomination & Governance
Committee, planning succession in Board appointments;

 

		·	oversight, where appropriate, of the Bank’s relationships with PRA and FCA and other government
and regulatory entities, maintaining regular dialogue and ensuring that these interactions complement those of the GCE; and

 

		·	taking responsibility for working with the GCE and, through the GCE, the executive, to ensure the
Board is presented with a clear strategy and high level business plan for approval, with sufficient opportunity for challenge and
debate and the subsequent oversight by the Board of its execution.

 

And in the shorter term:

 

		·	Management, with the GCE, of the Bank’s relationship with UKFI including the process by which
HMG’s stake in LBG is reduced; and

 

		·	oversight of the divestment by IPO or otherwise of the branch network constituting the Verde sale
and, if appropriate, the establishment of a separate Board for this activity.

 

And you retain the following responsibilities
as a Non Executive Director:

 

		·	provide sound leadership of the company within a framework of prudent and effective controls which
enable risk to be assessed and managed;

 

		·	set the company’s strategy having regard to its risk appetite, ensuring that the necessary
financial and human resources are in place for the company to meet its objectives, and review management performance; and

 

 

	1	Including the rolling
    forward programme

 

Page 3 of 7

    	 

    	

    

		·	set the company’s values and standards and ensure that its obligations to its shareholders
and others are met and understood.

 

		5	Time Commitment

 

As the Chairman, you are required
to devote such time as is necessary for the effective discharge of your duties. The estimated time commitment for your role is
approximately 3 - 4 days per week.

 

The estimated time commitment includes
scheduled Board and Committee meetings relevant to your role, plus strategy sessions (including offsite meetings), attendance at
the AGM and preparation for meetings.

 

On appointment as Chairman you
will be required to relinquish any other roles that compete or conflict with the Company’s business, or which will affect
your ability to meet the time commitment indicated below. You should discuss and agree with the current Chairman and the Senior
Independent Director, your proposals in this regard.

 

In your capacity as Chairman of
Lloyds Banking Group plc, you may be required to attend or represent the Group at meetings with the regulator, the Government,
investors or other third parties as appropriate.

 

By accepting this appointment,
you confirm that you are able to allocate sufficient time to meet the expectations of your role to the satisfaction of the board.

 

The agreement of the Senior Independent
Director should be sought before accepting additional commitments that might affect your ability to meet the time commitments necessary
to discharge your duties.

 

		6	Fees and Expenses

 

In consideration of your appointment
as Chairman, the company will pay you a fee at the rate of £700,000 per annum (“annual fees”) and provide the
following benefits:

 

		·	Life cover providing for a payment equal to four times your annual fees in the event of your death
during the term of this agreement provided you comply with any eligibility requirements or other conditions from time to time set
by the company.

 

		·	A cash allowance of £1,000 payable each month (£12,000 per annum) in lieu of a company
car.

 

		·	Membership of the company’s medical plan subject to the rules of the plan from time to time,
including eligibility rules. You will also be entitled to receive an executive confidential annual medical screening.

 

		·	Secretarial services and the services of a company driver.

 

You will be responsible for the
payment of any tax in relation to the provisions of these benefits.

 

Your annual fees cover all services
performed by you for any member of the Lloyds Banking Group and its subsidiaries.

 

Your annual fees will accrue
on a daily basis and be payable monthly in arrears less any tax and national insurance contributions the company is obliged
to pay. These fees will be subject to an annual review by the Remuneration Committee of the company. Fees will be paid into a
bank account held in your name with Lloyds Bank or any of the Lloyds Banking Group banking brands.

 

Page 4 of 7

    	 

    	

    

If for any reason related to illness,
disability or injury, you are unable to carry out your duties, payment of any fees during the period of incapacity will be at the
discretion of the Remuneration Committee, after the first 3 months of incapacity.

 

		7	Outside Interests

 

It is accepted and acknowledged
that you have business interests other than those of the company. As a condition of your appointment you are required to declare
any such directorships, appointments and interests to the Board in writing. If you take on any additional business interests or
become aware of any potential conflicts of interest, these must be disclosed to the Board as soon as they arise or become known
to you. If at any time you are considering acquiring any new interest which might give rise to a conflict of interest with the
company you must first discuss the matter with the Senior Independent Director and obtain a resolution of the Board authorising
such interest. Regardless of any approval given in relation to outside interests, it is your responsibility to ensure that you
can meet the time commitment required by the role.

 

		8	Confidentiality

 

You will not use or disclose to
any person, firm or organisation (except as required by law or to carry out your duties under this letter) any trade secrets, know-how,
business information or other private or confidential information relating to the business, finances or affairs of the company
or any member of the Lloyds Banking Group, or any customer of any such company or any other information provided on the basis that
it is confidential. You will use your best endeavours to prevent the unauthorised use or disclosure of any such information.

 

This restriction will continue
to apply after your appointment ends without limit in time but will not apply to information which becomes public, unless through
unauthorised disclosure by you. After your appointment ends you will return all documents and information (whether written, visual
or electronic) under your control which belong to the company or any member of the Lloyds Banking Group.

 

Your attention is also drawn to
the requirements under both legislation and regulation relating to the disclosure of price sensitive information. You should avoid
making any statements or engaging in any dealings that might contravene these requirements. The Company Secretary can provide further
information and advice on these matters if required. Company policy is that all external communication on company affairs is restricted
to the Chairman, the Group Chief Executive and Group Director, Corporate Affairs only. If you wish to undertake media training
at any time prior to or during your appointment as Chairman, this can be arranged via the Group Director, Corporate Affairs.

 

		9	Evaluation and review of performance

 

The Chairman’s annual performance
review is conducted annually by the Senior Independent Director. As Chairman, you are responsible for leading the annual effectiveness
review of the Board, its committees and individual directors.

 

		10	Directors’ Liability Indemnity and Insurance

 

To the extent permitted by law,
directors are entitled to be indemnified by the company against all costs and liabilities incurred by them in execution of their
duties. In this regard, your indemnity dated 1 June 2012 remains in full force and effect.

 

Page 5 of 7

    	 

    	

    

You will also have the benefit
of any directors’ and officers’ insurance cover maintained from time to time by the company (subject to the proviso
that this shall not oblige the company to maintain such cover at all, or on the same terms as is currently in place).

 

		11	Independent Professional Advice

 

Occasions may arise when you consider
that you need professional advice in the furtherance of your duties as a director and it will be appropriate for you to consult
independent advisers at the company’s expense. The company will reimburse the full cost of expenditure incurred.

 

		12	Disclosure and Dealings in Shares

 

The company may be required to
include in its annual accounts a note of any material interest that a director may have in any transaction or arrangement that
the company has entered into. You must disclose any such interest as soon as possible but no later than the board meeting at which
the transaction or arrangement is first discussed so that the Board can note your interest and, if appropriate, approve any conflicts.
A general notice that you are interested in any contracts with a particular person, firm or company is acceptable.

 

During the continuation of your
appointment you will be expected to comply (and to procure that your spouse and any connected persons comply) where relevant with
any rule of law or regulation of any competent authority or of the company from time to time in force in relation to dealings in
shares, debentures and other securities of the company and the unpublished price sensitive information affecting the shares, debentures
and other securities of the company.

 

Details of the procedure for dealing
in shares, together with explanatory notes on the code of market conduct/model code, were provided on your appointment as a non
executive director. A copy is available from the Company Secretary. You should note that, as Chairman, the Model Code provides
that you (or your connected persons) must not deal in any securities of the company without first notifying the Group Chief Executive
and receiving clearance to deal from him or, in his absence the Senior Independent Director.

 

Directors (and their connected
persons) are required to seek permission from you as Chairman, prior to dealing on their own behalf.

 

		13	Shareholdings

 

All directors are encouraged to
hold shares in the company. If you would like to receive whole or part of your monthly fee in shares, we would be happy to make
the necessary arrangements for you.

 

Please acknowledge receipt and acceptance
of the above terms by signing and returning the enclosed copy of this letter.

 

Please do not hesitate to contact me for
any assistance in any matters during the term of your appointment.

 

Page 6 of 7

    	 

    	

    

Yours sincerely

 

Tony Watson

Senior Independent Director

Lloyds Banking Group plc

 

I acknowledge receipt of the letter of which
this is a copy and accept the terms of appointment.

 

	 	 	}
	EXECUTED as a DEED by me

    Lord Norman Blackwell	 
	 	 

 

on ________________ (Date)

in the presence of:

 

Witness’s signature:

 

Name:

 

Address:

 

Occupation:

 

Page 7 of 7Exhibit  4(b)(xiii)

 

1 April 2014

 

Private & Confidential

 

Nick Prettejohn

 

Non - Executive Director Appointment
- Lloyds Banking Group plc

 

Following our recent discussions, I am
pleased to confirm my invitation for you to join the Board of Lloyds Banking Group plc (“the company”) and certain
subsidiary boards as a Non-Executive Director, subject to regulatory approval. Your appointment will be confirmed by the boards
once regulatory approval has been obtained.

 

	1.	Appointments

 

Subject to your acceptance of the terms
and conditions set out in this letter, you are invited to serve as:

 

	(i)	Non-Executive Director of the board of Lloyds Banking Group plc (the ‘Main
    Board Appointment’);
	 	 
	(ii)	Non-Executive Director of the board of each of the following principal subsidiaries:

 

	 	-	Lloyds Bank plc
	 	-	HBOS Plc
	 	-	Bank of Scotland plc; and

 

	(iii)	Chairman of Scottish Widows Group Limited and each of its principal subsidiaries
    (collectively referred to as ‘the Insurance Boards’).

 

Your appointments will commence on Monday,
23 June 2014 and are for an initial term of three years, expiring at the company’s Annual General Meeting (AGM) in 2017.
Appointments are reviewable annually. Subject to satisfactory performance and board approval, you will be invited to stand for
annual re-election by shareholders at the company’s AGM in each year of your appointment.

 

Subject to a review of performance and
the requirements of the board at the time, Non-Executive Directors may be invited to serve for a further term.

 

Continuation of your appointments is subject
to:

 

	·	confirmation by the Prudential Regulatory Authority (PRA) and Financial Conduct Authority (FCA) that
    your application to carry out the non executive director controlled function as an approved person has been approved and to
    this status being

    	 

    	

    

	 	maintained throughout your tenure. All directors are required to adhere to the standards set by the
    regulator in relation to approved persons. Current requirements are set out in the Statements of Principle and Code of Practice
    for Approved Persons (APER), a copy of which is included in your appointment pack. Directors are reminded that they must inform
    the company, PRA and FCA of any significant changes in their personal circumstances which may have an impact on their status
    as approved persons/director;
	 	 
	·	satisfactory performance and contribution to the board and any board committees on which you serve; and
	 	 
	·	election and re-election as a director by the company’s shareholders in general meeting as required by the company’s
    articles of association and codes to which the company subscribes, in particular, the Financial Reporting Council’s
    UK Corporate Governance Code.
	 	 
	2.	Termination
	 	 
	You will cease to hold the office of director if:
	 	 
	(i)	you resign from your appointment(s) or choose not to stand for re-election;
	 	 
	(ii)	the company terminates your appointment(s) or chooses not to propose you for re-election;
	 	 
	(iii)	shareholders fail to elect or re-elect you;
	 	 
	(iv)	you fail to meet, on an ongoing basis, the standards expected of an approved person; or
	 	 
	(v)	the articles of association or any law or regulation prevents you from continuing in office.

 

In the case of (i) and (ii) above, there
is no entitlement to notice or to compensation for loss of office. However, the company will endeavour to give you reasonable
notice where appropriate. You are requested to make the Chairman of the company aware of any intention not to seek re-election
so that the boards can plan for orderly succession.

 

In the case of termination under (iii),
(iv) or (v) above, your appointment will terminate automatically with immediate effect and without compensation.

 

	3.	Board Committees

 

In addition to your appointment as a Non-Executive
Director of the company, you will be required to serve on at least two board committees which may be subject to rotation. You
will initially serve as a member of the Audit Committee and Board Risk Committee.

 

You may also be required to serve on ad
hoc board committees established from time to time for a specific purpose.

 

	4.	Role

 

Your duties will be those required of a
Non-Executive Director. In the case of the Insurance Boards, your duties will also include those of Chairman.

 

	(a)	Non-Executive Director

 

Non-Executive Directors have the same legal
responsibilities as other directors. The board as a whole is collectively responsible for promoting the success of the company
by directing the company’s affairs. As members of the unitary board, all directors are required to:

    	2

    	

    

	(i)	provide sound leadership of the company within a framework of prudent and effective
    controls which enable risk to be assessed and managed;
	 	 
	(ii)	set the company’s strategy having regard to its risk appetite, ensuring that the necessary
    financial and human resources are in place for the company to meet its objectives, and review management performance; and
	 	 
	(iii)	set the company’s values and standards and ensure that its obligations to its shareholders
    and others are met and understood.
	 	 
	(b)	Chairman, Insurance Boards
	 	 
	As Chairman of the Insurance Boards, you will be responsible for leadership of the Insurance Boards, including:
	 	 
	(i)	running the Insurance Boards and setting their agenda;
	 	 
	(ii)	ensuring that directors receive accurate, timely and clear information and that the Insurance
    Boards as a whole are devoting time to the right matters;
	 	 
	(iii)	managing the Insurance Boards and facilitating a culture of open debate, ensuring that sufficient
    time is allowed for discussion of complex or contentious issues;
	 	 
	(iv)	ensuring that the composition of the Insurance Boards is appropriate for the efficient running
    of the business; and
	 	 
	(v)	evaluating the overall effectiveness of the Insurance Boards including the collective and
    individual performance of directors.
	 	 
	5.	Key accountabilities

 

Non-Executive Directors are expected to
focus on the following key areas:

 

	Strategy	Non-Executive Directors should constructively challenge management and help to develop proposals on
    strategy by bringing a different and external perspective to board discussions.
	 	 
	Performance	Non-Executive Directors should support and scrutinise the performance of management in meeting agreed goals and objectives
    and monitor the reporting of performance.
	 	 
	Risk	Non-Executive Directors should satisfy themselves that board discussion and decision making on risk matters is based on
    accurate and appropriately comprehensive information and draws, as far as they believe it to be relevant or necessary, on
    external analysis and input. In particular, non-executive directors should satisfy themselves on the integrity of financial
    information and that financial controls and systems of risk management are robust, adequate and effective.
	 	 
	People	Through membership of board committees, Non-Executive Directors are responsible for determining appropriate policies,
    structure and levels of remuneration for executive directors and senior executive management and ensuring appropriate arrangements
    are in place for board appointments and Executive and Non-Executive Director succession planning.

 

	6.	Time Commitment

 

As a Non-Executive Director, you are required
to devote such time as is necessary for the effective discharge of your duties. The estimated time commitment for your role is
approximately 70 - 80 days per annum which is made up as follows:

    	3

    	

    

	·	Base time commitment for Lloyds Banking Group Non-Executive Directors:	 	c.25 - 28 days
	·	Additional time for membership of Audit Committee	 	c.5- 6 days
	·	Additional time for membership of Board Risk Committee	 	c.5- 6 days
	·	Additional time for Chairmanship of Insurance Boards	 	35- 40 days

 

The boards of the principal banking subsidiaries
generally meet simultaneously with the board of Lloyds Banking Group plc.

 

The estimated time commitment includes
scheduled board and committee meetings relevant to your role, plus strategy sessions (including a 2- 3 day offsite meeting),
attendance at the AGM and preparation for meetings. A schedule of board and committee meetings is included in your appointment
pack.

 

The above time commitment is based on planned
events. From time to time, you may be required to attend meetings at short notice. In such cases, you will be required to make
yourself available as appropriate. Depending on your other commitments, you may be expected to relinquish other appointments to
ensure that you can meet the time commitments of the role.

 

In your capacity as a director of the company,
you may be required to attend or represent the Group at meetings with the regulator, the Government, investors or other third
parties as appropriate.

 

By accepting these appointments, you confirm
that you are able to allocate sufficient time to meet the expectations of your role to the satisfaction of the board.

 

The agreement of the Chairman should be
sought before accepting additional commitments that might affect your ability to meet the time commitments necessary to discharge
your duties.

 

	7.	Fees and Expenses 

 

The following fees are payable in respect of your
appointment:

 

	·	Non-Executive Director base fee:	 	£ 65,000
	·	Additional fee for membership of Audit Committee	 	£ 20,000
	·	Additional fee for membership of Board Risk Committee	 	£ 20,000
	·	Additional fee for Chairmanship of Insurance Boards	 	£245,000
	 	 	 	 
	Total fees payable:	 	£ 350,000

 

As the boards of the principal banking
subsidiaries meet simultaneously with the board of Lloyds Banking Group plc, there is no separate fee.

 

Fees are payable monthly in sterling and
will be paid to a Lloyds bank account (or an account with any of the Lloyds Banking Group brands), held in your name. If you do
not hold such an account, you will be required to open one for this purpose. Please contact the Company Secretary who will be
happy to make the necessary arrangements.

 

The company will reimburse you for all
reasonable and properly documented expenses incurred by you in the performance of your duties.

 

	8.	Outside Interests

 

It is accepted and acknowledged that you
have business interests other than those of the company. As a condition of your appointment you are required to declare any such
directorships, appointments and interests to the board in writing. If you take on any additional business interests or become
aware of any potential conflicts of interest, these

    	4

    	

    

must be disclosed to the board as soon
as they arise or become known to you. If at any time you are considering acquiring any new interest which might give rise to a
conflict of interest with the company you must first discuss the matter with the Chairman and obtain a resolution of the board
authorising such interest. Regardless of any approval given in relation to outside interests, it is your responsibility to ensure
that you can meet the time commitment required by the role.

 

	9.	Confidentiality

 

You will not use or disclose to any person,
firm or organisation (except as required by law or to carry out your duties under this letter) any trade secrets, know-how, business
information or other private or confidential information relating to the business, finances or affairs of the company, or any
customer of the company or any other information provided on the basis that it is confidential. You will use your best endeavours
to prevent the unauthorised use or disclosure of any such information.

 

This restriction will continue to apply
after your appointment ends without limit in time but will not apply to information which becomes public, unless through unauthorised
disclosure by you. After your appointment ends you will return all documents and information (whether written, visual or electronic)
under your control which belong to the company or any member of the Lloyds Banking Group. In respect of your main board appointment,
your attention is also drawn to the requirements under both legislation and regulation relating to the disclosure of price sensitive
information. You should avoid making any statements or engaging in any dealings that might contravene these requirements. The
Company Secretary can provide further information and advice on these matters if required. Company policy is that all external
communication on company affairs is restricted to the Chairman, Chief Executive and Corporate Affairs Director only.

 

	10.	Induction

 

Following appointment, the company will
provide further tailored induction to the extent required. You are entitled to request any additional information or briefings
to assist you in the execution of your duties.

 

	11.	Evaluation and review of performance

 

The performance of individual directors
and the board and its committees is evaluated annually. In the interim, if there are any matters which you wish to discuss in
relation to your role, please feel free to contact the Chairman.

 

	12.	Directors’ Liability Indemnity and Insurance

 

To the extent permitted by law, directors
are entitled to be indemnified by the company against all costs and liabilities incurred by them in execution of their duties.
A deed of indemnity is included in your appointment pack for signature and return.

 

You will also have the benefit of any directors’
and officers’ insurance cover maintained from time to time by the company (but this shall not oblige the company to maintain
any such cover either at all, or on current terms).

 

	13.	Independent Professional Advice

 

Occasions may arise when you consider that
you need professional advice in the furtherance of your duties as a director and it will be appropriate for you to consult independent
advisers at the company’s expense. The company will reimburse the full cost of expenditure incurred.

    	5

    	

    
	14.	Disclosure and Dealings in Shares

 

The company may be required to include
in its annual accounts a note of any material interest that a director may have in any transaction or arrangement that the company
has entered into. You must disclose any such interest as soon as possible but no later than the board meeting at which the transaction
or arrangement is first discussed so that the board can note your interest and, if appropriate, approve any conflicts. A general
notice that you are interested in any contracts with a particular person, firm or company is acceptable.

 

During the continuation of your appointment
you will be expected to comply (and to procure that your spouse and any connected persons comply) where relevant with any rule
of law or regulation of any competent authority or of the company from time to time in force in relation to dealings in shares,
debentures and other securities of the company and the unpublished price sensitive information affecting the shares, debentures
and other securities of the company.

 

Details of the procedure for dealing in
shares, together with explanatory notes on the code of market conduct/model code, will be in your appointment pack.

 

	15.	Shareholdings

 

All directors are encouraged to hold shares
in the company. If you would like to receive whole or part of your monthly fee in shares, we would be happy to make the necessary
arrangements for you.

 

Please acknowledge receipt and acceptance
of the above terms by signing and returning the enclosed copy of this letter.

 

Please do not hesitate to contact me for
any assistance in any matters during the term of your appointment. I look forward to welcoming you to the board.

 

	 	 	 	 	 
	 	 	 	 	 
	Sir Winfried Bischoff	 	Lord Blackwell	 
	Chairman	 	 	Chairman - designate
	Lloyds Banking Group plc	 	Lloyds Banking Group plc

    	6

    	

    

I acknowledge receipt of the letter dated
1 April 2014 of which this is a copy and accept the terms of appointment.

 

	 	 
	Signed 	 
	 	 
	 	 
	Name: Nick Prettejohn
	 	 
	 	 
	Date	 

    	7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]